A study published in Epic Research found that, after taking Paxlovid, COVID-19 patients were five times less likely to be hospitalized and ten times less likely to die. Paxlovid is “an oral...
The Kaiser Family Foundation (KFF) recently found that pediatric COVID-19 vaccination rates in children under 5 years old have decreased despite the age bracket’s very recent eligibility....
According to a cross-sectional survey study published in JAMA, remote and decentralization tools can improve clinical trial enrollment and participation in cancer studies.
Recently, many...
HRA Pharma has submitted an FDA application to allow the OTC sale of their progestin-only daily birth control pill, Opill. If this application is approved, this will be the first birth control pill...
Recently, the FDA expanded its emergency use authorization (EUA) for Paxlovid, an oral antiviral medication. This expansion permits pharmacists to prescribe this antiviral medication to patients...
On June 30, the FDA released a drug safety communication that warned against the risks associated with Copiktra. Copiktra, also called duvelisib, is a cancer drug used to treat relapsed or...
The FDA recently approved Skyrizi as a treatment for moderate to severely active Crohn’s disease. Crohn’s disease is an inflammatory bowel disease (IBD) with many painful symptoms that can...
Pfizer has announced or completed the acquisition of four pharmaceutical companies in the past year. The most recent of which incorporated ReViral Ltd, adding another antiviral drugmaker to...
The FDA recently approved the Imcivree (setmelanotide) injection as a weight-management treatment for adults and children over 6 with Bardet–Biedl Syndrome (BBS). BBS is a relatively...
Earlier this month, Beta Bionics presented clinical trial data to the American Diabetes Association (ADA) on its insulin-only bionic pancreas — called the iLet Bionic Pancreas — for use in...
This week, Health Canada announced its approval of Albrioza (created by Amylyx Pharmaceuticals) for the treatment of ALS. It has been the only newly approved treatment for ALS since 2018. The drug is...
The FDA recently accepted Merck’s Biologics License Application (BLA) for its cancer medication Keytruda. Promising results from interim clinical trial data indicated that Keytruda improved...
Monday’s FDA approval of Olumiant for the treatment of Alopecia Areata (AA) marks a historical change in the procedures used to address Alopecia Areata as it is the first systemic therapy for the...
A former employee of Eli Lilly is suing the company, claiming she was terminated after exposing issues with pharmaceutical manufacturing practices at one United States operation. Amrit Mula said that...
Last week, the FDA Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) voted 15 – 0, concluding that the benefits of bluebird bio’s gene therapy to treat cerebral...
The FDA Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0 in favor of recommending the Novavax coronavirus vaccine for emergency...
Aeglea BioTherapuetics announced that it had failed to secure a biologics license application (BLA) from the FDA after administrators issued a refusal to file for the company’s biologic...
Late last month, Pfizer announced its coronavirus vaccine clinical trial results, indicating that a three-dose regimen of the Pfizer-BioNTech vaccine was safe and effective for children older than 6...
According to the FDA’s enforcement report, Nephron Sterile Compounding Center, in Columbia, South Carolina, is recalling 2,158,351 medical products including syringes and bags because of a lack...
Data from a study published in February's CDC Morbidity and Mortality Weekly Report suggest that COVID-19 vaccination during pregnancy provides substantial protection for mother and baby.
This...
